ClinicalTrials.Veeva

Menu

Open-Label Placebo for Functional Dyspepsia

Beth Israel Lahey Health logo

Beth Israel Lahey Health

Status and phase

Terminated
Early Phase 1

Conditions

Dyspepsia

Treatments

Drug: Placebos

Study type

Interventional

Funder types

Other

Identifiers

NCT03745781
2018P000294

Details and patient eligibility

About

The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.

Enrollment

21 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Functional Dyspepsia

Exclusion criteria

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

21 participants in 2 patient groups

open-label placebo
Experimental group
Description:
open-label placebo
Treatment:
Drug: Placebos
treatment as usual
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems